Benign Essential Blepharospasm Res… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Principal Officer

Charlene Hudgins

Phone

4098320788

Tax Period

2024-01-01 to 2024-12-31

Benign Essential Blepharospasm Research Foundation Inc, founded in 1981, is a small nonprofit in the Medical Research sector that reported $809K in total revenue in fiscal year 2024. Revenue surged 91% from the prior year, signaling strong growth momentum. The organization ran a surplus of $564K, a strong 70% operating margin.

Mission

Education and research funding pertaining to benign essential blepharospasm and related conditions

Program Service Accomplishments

Program 1

Expenses: $165,542 Revenue: $0

Provide education and funding for research regarding benign essential blepharospasm and related conditions

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $691,734

Program Service Revenue $0

Investment Income $117,391

Other Revenue $44

TOTAL REVENUE $809,169

Expense Breakdown

Grants Paid $0

Salaries & Benefits $109,179

Fundraising Expenses $40,317

Program Expenses $165,542

Other Expenses $135,564

TOTAL EXPENSES $244,743

Year-over-Year Comparison

	2024	2023	Change
Revenue	$809,169	$423,809	+0.9%
Expenses	$244,743	$241,465	+0.0%
Net Income	$564,426	$182,344	+2.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

100

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$59,500

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Heidi Coggeshall	President	2.00	Officer Director	$0	$0	$0
Brenda Rarick	Treasurer	5.00	Officer Director	$0	$0	$0
Peter Bakalor	VP of Development	2.00	Officer Director	$0	$0	$0
Eda Tekeoglu	Vice President	2.00	Officer Director	$0	$0	$0
Tishana Cundiff	VP - Education & Support	1.00	Officer Director	$0	$0	$0
Jonathan Healy	Director	0.50	Director	$0	$0	$0
Carlas Powell	Director	1.00	Director	$0	$0	$0
Bryan Renehan	Director	1.00	Director	$0	$0	$0
Cynthia Clark	Director	1.00	Director	$0	$0	$0
Gina Duvasaint	Director	2.00	Director	$0	$0	$0
Christopher West	Director	1.00	Director	$0	$0	$0
Charlene Hudgins	Executive Director	40.00	Key Emp	$59,500	$0	$59,500

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$809,169	$244,743	$2,691,107	$564,426
2022	$370,429	$223,613	$1,832,628	$146,816
2021	$511,633	$202,844	$1,823,419	$308,789
2020	$174,275	$292,130	$1,500,213	$-117,855
2019	$264,958	$327,096	$1,580,335	$-62,138
2018	$248,139	$360,946	$1,579,461	$-112,807

Benign Essential Blepharospasm Research Foundation Inc